Sale!

Influenza A RNA Detection Qualitative Test

850 د.إ

-15%

The “Influenza A RNA Detection Qualitative Test” is a diagnostic tool designed to identify the presence of Influenza A virus RNA in a patient’s sample, typically obtained from a respiratory swab. This test employs advanced molecular techniques to specifically detect the genetic material of the Influenza A virus, allowing for a highly accurate diagnosis of influenza A infections. The qualitative nature of the test means that it indicates whether the virus is present or not, rather than measuring the amount of viral RNA.

Conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive range of diagnostic services, the test is pivotal in guiding the clinical management of patients, especially during the flu season or in cases of suspected influenza outbreaks. With a cost of 850 AED, the test is accessible to individuals seeking a prompt and reliable diagnosis. The result from this test can significantly influence treatment decisions, including the need for antiviral therapy, thereby playing a crucial role in patient care and infection control measures.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Influenza A RNA Detection Qualitative Test

Test Name: Influenza A RNA Detection Qualitative Test

Components: RNA Detection Kit

Price: AED 850.0

Sample Condition: Deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat or bronchial aspirate

Report Delivery: 3rd Working Day Email: 36 hours. On phone: 24 hours

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Consent document signature required. Bring any clinical history of patient for Influenza A (RNA Detection) Qualitative Test

Test Details

The Influenza A RNA Detection Qualitative Test is a diagnostic test used to detect the presence of Influenza A virus RNA in a patient’s sample. This test is typically performed on respiratory specimens, such as nasal or throat swabs, to diagnose Influenza A infection.

The test uses a technique called reverse transcription polymerase chain reaction (RT-PCR) to amplify and detect specific genetic material (RNA) of the Influenza A virus. RT-PCR involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using specific primers and a DNA polymerase enzyme. The amplification process is repeated multiple times, which increases the amount of viral genetic material present in the sample.

The presence of Influenza A virus RNA is detected by a fluorescent probe that binds to the amplified DNA during each cycle of the PCR reaction. The fluorescence signal is measured and analyzed to determine if the sample is positive or negative for Influenza A virus.

The Influenza A RNA Detection Qualitative Test is highly sensitive and specific, providing accurate and reliable results. It can differentiate between different subtypes of Influenza A virus, such as H1N1 or H3N2.

This test is commonly used during influenza outbreaks to quickly identify infected individuals and guide appropriate treatment and infection control measures. It is important to note that this test specifically detects Influenza A virus and does not detect other respiratory viruses, such as Influenza B or respiratory syncytial virus (RSV). Separate tests may be required to identify these viruses.

Test Name Influenza A RNA Detection Qualitative Test
Components
Price 850.0 AED
Sample Condition Deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat or bronchial aspirate.
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forInfluenzaA (RNA Detection) QualitativeTest
Test Details

The Influenza A (RNA Detection) Qualitative Test is a diagnostic test used to detect the presence of Influenza A virus RNA in a patient’s sample. This test is typically performed on respiratory specimens, such as nasal or throat swabs, to diagnose Influenza A infection.

The test uses a technique called reverse transcription polymerase chain reaction (RT-PCR) to amplify and detect specific genetic material (RNA) of the Influenza A virus. RT-PCR involves converting the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using specific primers and a DNA polymerase enzyme.

The amplification process is repeated multiple times, which increases the amount of viral genetic material present in the sample. The presence of Influenza A virus RNA is detected by a fluorescent probe that binds to the amplified DNA during each cycle of the PCR reaction. The fluorescence signal is measured and analyzed to determine if the sample is positive or negative for Influenza A virus.

The Influenza A (RNA Detection) Qualitative Test is highly sensitive and specific, providing accurate and reliable results. It can differentiate between different subtypes of Influenza A virus, such as H1N1 or H3N2. This test is commonly used during influenza outbreaks to quickly identify infected individuals and guide appropriate treatment and infection control measures.

It is important to note that this test specifically detects Influenza A virus and does not detect other respiratory viruses, such as Influenza B or respiratory syncytial virus (RSV). Separate tests may be required to identify these viruses.